NCT02607436View on ClinicalTrials.gov

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

April 30, 2016

Conditions
Coronary Artery Disease
Interventions
DRUG

Sarpogrelate

Sarpogrelate

DRUG

Aspirin

Aspirin

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02607436 - Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease | Biotech Hunter | Biotech Hunter